Effects of prophylactic antibiotic therapy with mezlocillin plus sulbactam on the incidence and height of fever after severe acute ischemic stroke: The Mannheim Infection in Stroke Study (MISS)

Stroke

Volumn 39, Issue 4, 2008, Pages 1220-1227

  Schwarz, Stefan ^a,b   Al Shajlawi, Frank ^a   Sick, Christian ^a   Meairs, Stephen ^a   Hennerici, Michael G ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Acute stroke; Antibiotic prophylaxis; Fever; Hyperthermia; Infection

Indexed keywords

LIVER ENZYME; MEZLOCILLIN; SULBACTAM;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; BODY TEMPERATURE MONITORING; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORE TEMPERATURE; ENZYME BLOOD LEVEL; FEMALE; FEVER; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; RASH; SIDE EFFECT; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BRAIN ISCHEMIA; DRUG THERAPY, COMBINATION; FEMALE; FEVER; HUMANS; INCIDENCE; MALE; MEZLOCILLIN; MIDDLE AGED; PILOT PROJECTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STROKE; SULBACTAM; TREATMENT OUTCOME;

EID: 41149174283     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.499533     Document Type: Article

References (33)

1. Hajat C, Hajat S, Sharma P. Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients. Stroke. 2000;31:410-414.
2. Ginsberg MD, Busto R. Combating hyperthermia in acute stroke: a significant clinical concern. Stroke. 1998;29:529-534.
3. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF. Guidelines for the early management of adults with ischemic stroke. Stroke. 2007;38:1655-1711.
4. Sulter G, Elting JW, Maurits N, Luyckx GJ, De Keyser J. Acetylsalicylic acid and acetaminophen to combat elevated body temperature in acute ischemic stroke. Cerebrovasc Dis. 2004;17:118-122.
5. Dippel DW, van Breda EJ, van der Worp HB, van Gemert HM, Meijer RJ, Kappelle LJ, Koudstaal PJ. Effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute ischemic stroke PISA, a phase II double-blind, randomized, placebo-controlled trial. BMC Cardiovasc Disord. 2003;3:2.
6. Kasner SE, Wein T, Piriyawat P, Villar-Cordova CE, Chalela JA, Krieger DW, Morgenstern LB, Kimmel SE, Grotta JC. Acetaminophen for altering body temperature in acute stroke: a randomized clinical trial. Stroke. 2002;33:130-134.
7. Koennecke HC, Leistner S. Prophylactic antipyretic treatment with acetaminophen in acute ischemic stroke: a pilot study. Neurology. 2001;57:2301-2303.
8. Diringer MN. Treatment of fever in the neurologic intensive care unit with a catheter-based heat exchange system. Crit Care Med. 2004;32:559-564.
9. Georgiadis D, Schwarz S, Schwab S. Endovascular cooling for moderate hypothermia in patients with acute stroke. First results of a novel approach. Stroke. 2001;32:2550-2553.
10. Commichau C, Scarmeas N, Mayer SA. Risk factors for fever in the neurological intensive care unit. Neurology. 2003;60:837-841.
11. Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke. 2003;34:2518-2532.
12. Dirnagl U, Klehmet J, Braun JS, Harms H, Meisel C, Ziemssen T, Prass K, Meisel A. Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke. 2007;38:770-773.
13. Naber KG, Bergman B, Bishop MC, Bjerklund-Johansen TE, Botto H, Lobel B, Jinenez Cruz F, Selvaggi FP. EAU guidelines for the management of urinary and male genital tract infections. Urinary tract infection (UTI) working group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol. 2001;40:576-588.
14. Vogel F, Bodmann KF. Empfehlungen zur kalkulierten parenteralen Initialtherapie bakterieller Infektionen bei Erwachsenen. Chemother J. 2004;13:46-105.
15. Adams HP Jr, Bendicksen BH, Kapelle LJ. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24:35-41.
16. Anderson CS, Taylor BV, Hankey GJ, Stewart-Wynne EG, Jamrozik KD. Validation of a clinical classification for subtypes of acute cerebral infarction. J Neurol Neurosurg Psychiatry. 1994;57:1173-1179.
17. van Nieuwenhoven CA, Buskens E, van Tiel FH, Bonten MJ. Relationship between methodological trial quality and the effects of selective digestive decontamination on pneumonia and mortality in critically ill patients. JAMA. 2001;286:335-340.
18. Barker FG II. Efficacy of prophylactic antibiotic therapy in spinal surgery: a meta-analysis. Neurosurgery. 2002;51:391-400.
19. Gumaste V. Prophylactic antibiotic therapy in the management of acute pancreatitis. J Clin Gastroenterol. 2000;31:6-10.
20. Majkowski J, Kunicka J, Szabelska K, Cendrowski W. Profilaktyczne stosowanie penicyliny g i ampicyliny w udarach mozgowych. I. Obserwacje kliniczne. Neurol Neurochir Pol. 1982;16:261-267.
21. Chamorro A, Horcajada JP, Obach V, Vargas M, Revilla M, Torres F, Cervera A, Planas AM, Mensa J. The early systemic prophylaxis of infection after stroke study: a randomized clinical trial. Stroke. 2005;36:1495-1500.
22. Castillo J, Davalos A, Marrugat J, Noya M. Timing for fever-related brain damage in acute ischemic stroke. Stroke. 1998;29:2455-2460.
23. Azzimondi G, Bassein L, Nonino F, Fiorani L, Vignatelli L, Re G, D'Alessandro R. Fever in acute stroke worsens prognosis. A prospective study. Stroke. 1995;26:2040-2043.
24. Harms H, Prass K, Halle E, Dirnagl U. Meisel A Preventive antibacterial therapy in stroke - results of the PANTHERIS trial. Cerebrovasc Dis. 2007;23(suppl 2):10.
25. Wildfeuer A, Schmalreck A, Rader K, Eibel G, Pfaff G. Studies on the synergism of sulbactam and beta-lactam antibiotics under in vitro conditions and in healthy volunteers after intravenous administration. Antibacterial activity in vitro, compatibility and pharmacokinetics of the drugs in combination. Arzneimittelforschung. 1989;39:94-100.
26. Rybak MJ. Resistance to antimicrobial agents: an update. Pharmacotherapy. 2004;24:203S-215S.
27. Sprandel KA, Rodvold KA. Safety and tolerability of fluoroquinolones. Clin Cornerstone. 2003;Suppl 3:S29-36.
28. Stahlmann R. Clinical toxicological aspects of fluoroquinolones. Toxicol Lett. 2002;127:269-277.
29. Aslanyan S, Weir CJ, Diener HC, Kaste M, Lees KR. Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN international trial. Eur J Neurol. 2004;11:49-53.
30. Nakagawa T, Sekizawa K, Arai H, Kikuchi R, Manabe K, Sasaki H. High incidence of pneumonia in elderly patients with basal ganglia infarction. Arch Intern Med. 1997;157:321-324.
31. Hilker R, Poetter C, Findeisen N, Sobesky J, Jacobs A, Neveling M, Heiss WD. Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke. 2003;34:975-981.
32. Vargas M, Horcajada JP, Obach V, Revilla M, Cervera A, Torres F, Planas AM, Mensa J, Chamorro A. Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials? Stroke. 2006;37:461-465.
33. Nystrom PO. The systemic inflammatory response syndrome: definitions and aetiology. J Antimicrob Chemother. 1998;41(suppl A):1-7.